<DOC>
	<DOCNO>NCT00625274</DOCNO>
	<brief_summary>This study look control intragastric pH follow administration esomeprazole 40 mg , lansoprazole 30 mg pantoprazole 40 mg take orally , daily patient take either non-selective cyclooxygenase-2 ( COX-2 ) selective nonsteroidal anti-inflammatory drug ( NSAIDs ) .</brief_summary>
	<brief_title>A Randomized , Open-Label , Comparative 3-Way Treatment Crossover Study 24-Hour Intragastric pH Profile Once Daily Oral Administration Esomeprazole 40mg , Lansoprazole 30mg , Pantoprazole 40mg Steady State NSAID-Using Patients</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>A medical diagnosis condition require daily Nonsteroidal AntiInflammatory Drugs ( NSAID ) treatment least 5 day per week 1 month prior enter study study . Some patient need undergo upper endoscopy screening . Signs clinically significant ( GI ) bleeding ( e.g. , melena , frank hematochezia ) time baseline EGD within 3 day prior randomization . History gastric esophageal surgery ( include limit Nissen fundoplication , bariatric surgery ( e.g . gastric staple RouxEnY gastric bypass ) , vagotomy , Billroth operation ) . Many exclusion criterion , please refer investigator site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Nexium</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>lansoprazole</keyword>
	<keyword>pantoprazole</keyword>
	<keyword>Nonsteroidal Anti-Inflammatory Drugs ( NSAIDs )</keyword>
</DOC>